secwatch.observer — SEC 8-K summary
======================================

Issuer:     Krystal Biotech, Inc. (KRYS)
CIK:        0001711279
Form:       8-K
Filed at:   2023-05-08T23:59:59+00:00
Accession:  0001193125-23-137744
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Krystal Biotech enters $150M ATM equity offering with Cowen
-----------------------------------------------------------

- Sales agreement with Cowen for at-the-market offering of up to $150M common stock.
- Cowen receives 3.0% commission on gross proceeds from each sale; no obligation to sell.
- Shares offered under existing shelf registration; proceeds for general corporate purposes.
- Either party may suspend or terminate the offering with notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711279/000119312523137744/0001193125-23-137744-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711279/000119312523137744/d431837d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-137744

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer